Aryl sulfonamides as chemokine receptor ccr9 antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 233/54 (2006.01) A61K 31/18 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61P 29/00 (2006.01) C07C 311/21 (2006.01) C07C 311/29 (2006.01) C07D 213/53 (2006.01) C07D 213/89 (2006.01) C07D 217/14 (2006.01) C07D 257/04 (2006.01) C07D 405/04 (2006.01) C07D 471/06 (2006.01)

Patent

CA 2566387

The present invention relates to compounds that modulate various chemokine receptors. These compounds are useful for treating inflammatory and immune diseases.

La présente invention porte sur des composés modulant divers chémocepteurs. Ces composés servent au traitement des maladies inflammatoires et immunitaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aryl sulfonamides as chemokine receptor ccr9 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl sulfonamides as chemokine receptor ccr9 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl sulfonamides as chemokine receptor ccr9 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1725095

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.